|
US - Boston Scientific Corp acquired the prolieve assets of Celsion Corp, a manufacturer of heat-activated cancer treatment products, for $## mil. The transaction had been subject to customary closing conditions and shareholders approval.…
|
| Credit & Investment Research |
|
|